Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1971 Apr;50(4):754–761. doi: 10.1172/JCI106546

On the lipoprotein abnormality in type III hyperlipoproteinemia

Steven Quarfordt 1, Robert I Levy 1, Donald S Fredrickson 1
PMCID: PMC291989  PMID: 5547274

Abstract

Two lipoprotein species were isolated by starch block electrophoresis from the very low density lipoproteins (VLDL) (Sf 20-400) of patients with type III hyperlipoproteinemia. One of these, α2-VLDL, had a content of lipid and protein and physical characteristics similar to VLDL from normal subjects or patients with other forms of hyperglyceridemia. The other species, β-VLDL, contained more cholesterol and less triglyceride in relation to the protein, than normal VLDL. Only the apoprotein of low density lipoprotein was immunochemically detectable in the β-VLDL; the proteins in the α2-VLDL reacted with antisera specific for low density lipoprotein and high density lipoprotein. The electrophoretic mobility of β-VLDL was similar to that of low density lipoprotein and significantly less than that of α2-VLDL. Isolated β-VLDL had a lesser mean flotation rate than α2-VLDL, but both α2- and β-VLDL were found throughout the Sf 20-400 flotation range.

The relative quantities of α2- and β-VLDL could be varied by changing the diet or by heparin administration. Most of the VLDL from type III patients on a high carbohydrate diet was in the α2-VLDL form. During fasting, α2-VLDL fell and β-VLDL increased becoming the predominant species of VLDL. Heparin-induced acceleration of triglyceride clearance also increased β-VLDL and decreased α2-VLDL. These findings suggest a precursor-product relationship between the α2- and β-forms of VLDL.

Full text

PDF
759

Images in this article

758Image
on p.758

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AVIGAN J. Modification of human serum lipoprotein fractions by lipide extraction. J Biol Chem. 1957 Jun;226(2):957–964. [PubMed] [Google Scholar]
  2. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  3. BURSTEIN M., SAMAILLE J. [On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins]. Clin Chim Acta. 1960 Jul;5:609–609. doi: 10.1016/0009-8981(60)90075-9. [DOI] [PubMed] [Google Scholar]
  4. DE LALLA O. F., GOFMAN J. W. Ultracentrifugal analysis of serum lipoproteins. Methods Biochem Anal. 1954;1:459–478. doi: 10.1002/9780470110171.ch16. [DOI] [PubMed] [Google Scholar]
  5. Ewing A. M., Freeman N. K., Lindgren F. T. The analysis of human serum lipoprotein distributions. Adv Lipid Res. 1965;3:25–61. [PubMed] [Google Scholar]
  6. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  7. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Feb 2;276(5):273–concl. doi: 10.1056/NEJM196702022760507. [DOI] [PubMed] [Google Scholar]
  8. Fredrickson D. S., Levy R. I., Lindgren F. T. A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques. J Clin Invest. 1969 Nov;47(11):2446–2457. doi: 10.1172/JCI105927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fredrickson D. S., Sloan H. R., Hansen C. T. Lipid abnormalities in foam cell reticulosis of mice, an analogue of human sphingomyelin lipidosis. J Lipid Res. 1969 May;10(3):288–293. [PubMed] [Google Scholar]
  10. GITLIN D., CORNWELL D. G., NAKASATO D., ONCLEY J. L., HUGHES W. L., Jr, JANEWAY C. A. Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins. J Clin Invest. 1958 Feb;37(2):172–184. doi: 10.1172/JCI103596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GORDON R. S., Jr Interaction between oleate and the lipoproteins of human serum. J Clin Invest. 1955 Mar;34(3):477–484. doi: 10.1172/JCI103097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. GRABAR P. Agar-gel diffusion and immunoelectrophoretic analysis. Ann N Y Acad Sci. 1957 Dec 16;69(4):591–607. doi: 10.1111/j.1749-6632.1957.tb49699.x. [DOI] [PubMed] [Google Scholar]
  13. GUSTAFSON A. A NEW METHOD FOR PARTIAL DELIPIDIZATION OF SERUM LIPOPROTEINS. Biochim Biophys Acta. 1964 Apr 20;84:223–225. doi: 10.1016/0926-6542(64)90088-5. [DOI] [PubMed] [Google Scholar]
  14. HAVEL R. J. Conversion of plasma free fatty acids into triglycerides of plasma lipoprotein fractions in man. Metabolism. 1961 Dec;10:1031–1034. [PubMed] [Google Scholar]
  15. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hatch F. T. Practical methods for plasma lipoprotein analysis. Adv Lipid Res. 1968;6:1–68. [PubMed] [Google Scholar]
  17. Hazzard W. R., Lindgren F. T., Bierman E. L. Very low density lipoprotein subfractions in a subject with broad-beta disease (Type 3 hyperlipoproteinemia) and a subject with endogenous lipemia (Type IV). Chemical composition and electrophoretic mobility. Biochim Biophys Acta. 1970 May 5;202(3):517–525. doi: 10.1016/0005-2760(70)90122-0. [DOI] [PubMed] [Google Scholar]
  18. KUNKEL H. G., TRAUTMAN R. The alpha2 lipoproteins of human serum; correlation of ultracentrifugal and electrophoretic properties. J Clin Invest. 1956 Jun;35(6):641–648. doi: 10.1172/JCI103320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. LEES R. S., HATCH F. T. Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer. J Lab Clin Med. 1963 Mar;61:518–528. [PubMed] [Google Scholar]
  20. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  21. Levy R. I., Lees R. S., Fredrickson D. S. The nature of pre beta (very low density) lipoproteins. J Clin Invest. 1966 Jan;45(1):63–77. doi: 10.1172/JCI105324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lossow W. J., Lindgren F. T., Murchio J. C., Stevens G. R., Jensen L. C. Particle size and protein content of six fractions of the Sf 20 plasma lipoproteins isolated by density gradient centrifugation. J Lipid Res. 1969 Jan;10(1):68–76. [PubMed] [Google Scholar]
  23. Nichols A. V., Strisower E. H., Lindgren F. T., Adamson G. L., Coggiola E. L. Analysis of change in ultracentrifugal lipoprotein profiles following heparin and ethyl-p-chlorophenoxyisobutyrate administration. Clin Chim Acta. 1968 May;20(2):277–283. doi: 10.1016/0009-8981(68)90160-5. [DOI] [PubMed] [Google Scholar]
  24. Oncley J. L., Harvie N. R. Lipoproteins--a current perspective of methods and concepts. Proc Natl Acad Sci U S A. 1969 Nov;64(3):1107–1118. doi: 10.1073/pnas.64.3.1107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. SCHEIDEGGER J. J. Une micro-méthode de l'immuno-electrophorèse. Int Arch Allergy Appl Immunol. 1955;7(2):103–110. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES